Across TCGA pan-cancer cohorts, OFD1P1Y RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OFD1P1Y’s most consistent transcriptional readouts.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where OFD1P1Y RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OFD1P1Y is over-expressed in tumor.
LIHC are the cancer types where OFD1P1Y tumor–normal differential expression is most reproducible.